Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis

Abstract

Chronic venous disease (CVD) is highly prevalent in the general population and encompasses a range of pathological and hemodynamic changes in the veins of the lower extremities. These alterations give rise to a variety of symptoms, with more severe forms resulting in venous ulceration, which causes morbidity and high socioeconomic burden. The origins and underlying mechanisms of CVD are intricate and multifaceted, involving environmental factors, genetics, hormonal factors, and immunological factors that bring about structural and functional alterations in the venous system. This review offers the latest insights into the epidemiology, pathophysiology, and risk factors of CVD, aiming to provide a comprehensive overview of the current state of knowledge. Furthermore, the diagnostic approach for CVD is highlighted and current diagnostic tools are described.

Keywords

chronic venous insufficiency - ultrasound - CEAP - genetics

Publication History

Received: 05 November 2023

Accepted: 25 April 2024

Article published online:
11 July 2024

• References

• 1 Eklof B, Perrin M, Delis KT, Rutherford RB, Gloviczki P. American Venous Forum, European Venous Forum, International Union of Phlebology, American College of Phlebology, International Union of Angiology. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 2009; 49 (02) 498-501
• 2 Fischer H. Socioepidemiologic study of venous disorders in the adult resident population of the Federal Republic of Germany. In: Voelter W, Jung G. eds. O-(β-Hydroxyethyl)-Rutoside. Springer; 1983: 121-134
• 3 Rabe E, Pannier-Fischer F, Bromen K. et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie: Epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003; 32 (01) 1-14
• 4 Kahle B, Stücker M. Diagnostik und Therapie der Varikosis. Aktuelle Derm 2009; 35 (06) 243-255
• 5 Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 1988; 4 (02) 96-101
• 6 Criqui MH, Jamosmos M, Fronek A. et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003; 158 (05) 448-456
• 7 Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15 (03) 175-184
• 8 Pannier F, Rabe E. Progression in venous pathology. Phlebology 2015; 30 (1, Suppl): 95-97
• 9 Lee AJ, Robertson LA, Boghossian SM. et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord 2015; 3 (01) 18-26
• 10 Caggiati A, Bergan JJ, Gloviczki P, Jantet G, Wendell-Smith CP, Partsch H. International Interdisciplinary Consensus Committee on Venous Anatomical Terminology. Nomenclature of the veins of the lower limbs: an international interdisciplinary consensus statement. J Vasc Surg 2002; 36 (02) 416-422
• 11 Caggiati A, Bergan JJ, Gloviczki P, Eklof B, Allegra C, Partsch H. International Interdisciplinary Consensus Committee on Venous Anatomical Terminology. Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application. J Vasc Surg 2005; 41 (04) 719-724
• 12 Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med (Korean Assoc Intern Med) 2019; 34 (02) 269-283
• 13 Goldman MP, Fronek A. Anatomy and pathophysiology of varicose veins. J Dermatol Surg Oncol 1989; 15 (02) 138-145
• 14 Baliyan V, Tajmir S, Hedgire SS, Ganguli S, Prabhakar AM. Lower extremity venous reflux. Cardiovasc Diagn Ther 2016; 6 (06) 533-543
• 15 Meissner MH, Moneta G, Burnand K. et al. The hemodynamics and diagnosis of venous disease. J Vasc Surg 2007; 46 (Suppl S): 4S-24S
• 16 Recek C. Calf pump activity influencing venous hemodynamics in the lower extremity. Int J Angiol 2013; 22 (01) 23-30
• 17 Raju S, Knepper J, May C, Knight A, Pace N, Jayaraj A. Ambulatory venous pressure, air plethysmography, and the role of calf venous pump in chronic venous disease. J Vasc Surg Venous Lymphat Disord 2019; 7 (03) 428-440
• 18 Meissner MH, Gloviczki P, Bergan J. et al. Primary chronic venous disorders. J Vasc Surg 2007; 46 (Suppl S): 54S-67S
• 19 Labropoulos N, Tiongson J, Pryor L. et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003; 38 (04) 793-798
• 20 Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA. Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest 2016; 126 (03) 821-828
• 21 Frati-Munari AC. Medical significance of endothelial glycocalyx. Arch Cardiol Mex 2013; 83 (04) 303-312
• 22 Giantsos-Adams KM, Koo AJA, Song S. et al. Heparan sulfate regrowth profiles under laminar shear flow following enzymatic degradation. Cell Mol Bioeng 2013; 6 (02) 160-174
• 23 Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg 2018; 46: 380-393
• 24 Raffetto JD. Pathophysiology of wound healing and alterations in venous leg ulcers-review. Phlebology 2016; 31 (1, Suppl): 56-62
• 25 Ligi D, Croce L, Mannello F. Chronic venous disorders: the dangerous, the good, and the diverse. Int J Mol Sci 2018; 19 (09) 2544
• 26 MacColl E, Khalil RA. Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease. J Pharmacol Exp Ther 2015; 355 (03) 410-428
• 27 Serra R, Ssempijja L, Provenzano M, Andreucci M. Genetic biomarkers in chronic venous disease. Biomarkers Med 2020; 14 (02) 75-80
• 28 Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg 2007; 45 (02) 373-380
• 29 Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins. J Vasc Surg 2008; 48 (02) 447-456
• 30 Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins - lessons from biomechanics. Vasa 2014; 43 (02) 88-99
• 31 Serra R, Gallelli L, Butrico L. et al. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. Int Wound J 2017; 14 (01) 233-240
• 32 Ortega MA, Fraile-Martínez O, García-Montero C. et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med 2021; 10 (15) 3239
• 33 Bonkemeyer Millan S, Gan R, Townsend PE. Venous ulcers: diagnosis and treatment. Am Fam Physician 2019; 100 (05) 298-305
• 34 Laurikka JO, Sisto T, Tarkka MR, Auvinen O, Hakama M. Risk indicators for varicose veins in forty- to sixty-year-olds in the Tampere varicose vein study. World J Surg 2002; 26 (06) 648-651
• 35 Franks PJ, Wright DD, Moffatt CJ. et al. Prevalence of venous disease: a community study in west London. Eur J Surg 1992; 158 (03) 143-147
• 36 Clark A, Harvey I, Fowkes FGR. Epidemiology and risk factors for varicose veins among older people: cross-sectional population study in the UK. Phlebology 2010; 25 (05) 236-240
• 37 Caggiati A, Rosi C, Heyn R, Franceschini M, Acconcia MC. Age-related variations of varicose veins anatomy. J Vasc Surg 2006; 44 (06) 1291-1295
• 38 Fukaya E, Flores AM, Lindholm D. et al. Clinical and genetic determinants of varicose veins. Circulation 2018; 138 (25) 2869-2880
• 39 Yuan S, Bruzelius M, Damrauer SM, Larsson SC. Cardiometabolic, lifestyle, and nutritional factors in relation to varicose veins: a Mendelian randomization study. J Am Heart Assoc 2021; 10 (21) e022286
• 40 Gourgou S, Dedieu F, Sancho-Garnier H. Lower limb venous insufficiency and tobacco smoking: a case-control study. Am J Epidemiol 2002; 155 (11) 1007-1015
• 41 Béliard S, Ferreira D, Thomas H, Mourot L, Tordi N. High physical activity volume is associated with an increase in the calibre of the lower limb veins without impact on functional discomfort: the VARISPORT study. Eur J Vasc Endovasc Surg 2023; 66 (06) 856-863
• 42 Xiang Y, Zhou Q, Wu Z, Gou J. Chronic venous insufficiency in a selected nurse population: a cross-sectional study. Angiology 2024; 75 (01) 29-35
• 43 Lee AJ, Lowe GD, Rumley A, Ruckley CV, Fowkes FG. Haemostatic factors and risk of varicose veins and chronic venous insufficiency: Edinburgh Vein Study. Blood Coagul Fibrinolysis 2000; 11 (08) 775-781
• 44 Komsuoğlu B, Göldeli O, Kulan K, Cetinarslan B, Komsuoğlu SS. Prevalence and risk factors of varicose veins in an elderly population. Gerontology 1994; 40 (01) 25-31
• 45 Benn S, Moore Z, Patton D. et al. What is the prevalence of chronic venous disease among health care workers? A scoping review. Int Wound J 2023; 20 (09) 3821-3839
• 46 Rabe E, Régnier C, Goron F, Salmat G, Pannier F. The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey. J Comp Eff Res 2020; 9 (17) 1205-1218
• 47 Xiang Y, Zhou Q, Wu Z, Gou J. Chronic venous insufficiency in a selected nurse population: a cross-sectional study. Angiology 2024; 75 (01) 29-35
• 48 Chen CL, Guo HR. Varicose veins in hairdressers and associated risk factors: a cross-sectional study. BMC Public Health 2014; 14: 885
• 49 Vlajinac HD, Marinkovic JM, Maksimovic MZ, Matic PA, Radak DJ. Body mass index and primary chronic venous disease – a cross-sectional study. Eur J Vasc Endovasc Surg 2013; 45 (03) 293-298
• 50 Jones WS, Vemulapalli S, Parikh KS. et al. Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD). Agency for Healthcare Research and Quality (US); 2017
• 51 Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995; 22 (05) 622-628
• 52 Mohr DN, Silverstein MD, Heit JA, Petterson TM, O'Fallon WM, Melton LJ. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc 2000; 75 (12) 1249-1256
• 53 Vlajinac HD, Radak DJ, Marinkovic JM, Maksimovic MZ. Risk factors for chronic venous disease. Phlebology 2012; 27 (08) 416-422
• 54 Robertson L, Evans C, Fowkes FGR. Epidemiology of chronic venous disease. Phlebology 2008; 23 (03) 103-111
• 55 Dindelli M, Parazzini F, Basellini A, Rabaiotti E, Corsi G, Ferrari A. Risk factors for varicose disease before and during pregnancy. Angiology 1993; 44 (05) 361-367
• 56 Radhakrishnan N. The pathophysiology of varicose veins of the lower limb. In: Radhakrishnan N. ed. Genesis, Pathophysiology and Management of Venous and Lymphatic Disorders. Academic Press; 2022: 95-137
• 57 Costa D, Andreucci M, Ielapi N. et al. Molecular determinants of chronic venous disease: a comprehensive review. Int J Mol Sci 2023; 24 (03) 1928
• 58 Smetanina MA, Shevela AI, Gavrilov KA, Filipenko ML. The genetic constituent of varicose vein pathogenesis as a key for future treatment option development. Vessel Plus 2021; 5: 19 https://www.oaepublish.com/articles/2574-1209.2021.17
• 59 Levin MG, Huffman JE, Verma A. et al. Genetics of varicose veins reveals polygenic architecture and genetic overlap with arterial and venous disease. Nat Cardiovasc Res 2023; 2 (01) 44-57
• 60 Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994; 20 (05) 318-326
• 61 Zöller B, Ji J, Sundquist J, Sundquist K. Family history and risk of hospital treatment for varicose veins in Sweden. Br J Surg 2012; 99 (07) 948-953
• 62 Fiebig A, Krusche P, Wolf A. et al. Heritability of chronic venous disease. Hum Genet 2010; 127 (06) 669
• 63 Helkkula P, Hassan S, Saarentaus E. et al; FinnGen. Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population. Commun Biol 2023; 6 (01) 71
• 64 Limandal HK, Kayğın MA, Özkaya AL. et al. The role of alpha-1-antitrypsin in the etiopathogenesis of chronic venous disease: a prospective clinical trial. Phlebology 2023; 38 (01) 16-21
• 65 Serra R, Buffone G, de Franciscis A. et al. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012; 26 (05) 636-642
• 66 Surendran S, Girijamma A, Nair R. et al. Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseases. PLoS One 2014; 9 (03) e90682
• 67 Surendran S, , S Ramegowda K, Suresh A. et al. Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway. Lab Invest 2016; 96 (04) 399-408
• 68 Kowalewski R, Małkowski A, Sobolewski K, Gacko M. Vascular endothelial growth factor and its receptors in the varicose vein wall. Acta Angiologica 2011; 17 (02) 141-149
• 69 Slonková V, Slonková Jr V, Vašků A, Vašků V. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2. J Eur Acad Dermatol Venereol 2017; 31 (10) 1746-1752
• 70 Lyons O, Walker J, Seet C. et al. Mutations in EPHB4 cause human venous valve aplasia. JCI Insight 2021; 6 (18) e140952
• 71 de Franciscis S, Metzinger L, Serra R. The discovery of novel genomic, transcriptomic, and proteomic biomarkers in cardiovascular and peripheral vascular disease: the state of the art. BioMed Res Int 2016; 2016: 7829174
• 72 Biranvand AS, Khosravi M, Esfandiari G. et al. Associations between miR-661, miR-1202, lncRNA-HOTAIR, lncRNA-GAS5 and MMP9 in differentiated M2-macrophages of patients with varicose veins. Int Angiol 2018; 37 (06) 451-456
• 73 Zalewski DP, Ruszel KP, Stępniewski A. et al. Dysregulations of MicroRNA and gene expression in chronic venous disease. J Clin Med 2020; 9 (05) 1251
• 74 Huang X, Liu Z, Shen L. et al. Augmentation of miR-202 in varicose veins modulates phenotypic transition of vascular smooth muscle cells by targeting proliferator-activated receptor-γ coactivator-1α. J Cell Biochem 2019; 120 (06) 10031-10042
• 75 Cao Y, Cao Z, Wang W, Jie X, Li L. MicroRNA‑199a‑5p regulates FOXC2 to control human vascular smooth muscle cell phenotypic switch. Mol Med Rep 2021; 24 (03) 627
• 76 Wang Y, Du J, Liu Y, Yang S, Wang Q. microRNA-301a-3p is a potential biomarker in venous ulcers vein and gets involved in endothelial cell dysfunction. Bioengineered 2022; 13 (06) 14138-14158
• 77 Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014; 130 (04) 333-346
• 78 Alsaigh T, Fukaya E. Varicose veins and chronic venous disease. Cardiol Clin 2021; 39 (04) 567-581
• 79 García-Honduvilla N, Asúnsolo Á, Ortega MA. et al. Increase and redistribution of sex hormone receptors in premenopausal women are associated with varicose vein remodelling. Oxid Med Cell Longev 2018; 2018: 3974026
• 80 Serra R, Gallelli L, Perri P. et al. Estrogen receptors and chronic venous disease. Eur J Vasc Endovasc Surg 2016; 52 (01) 114-118
• 81 Raffetto JD, Qiao X, Beauregard KG, Khalil RA. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins. J Vasc Surg 2010; 51 (04) 972-981
• 82 Kendler M, Makrantonaki E, Tzellos T. et al. Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg 2010; 51 (03) 639-646
• 83 Ropacka-Lesiak M, Kasperczak J, Breborowicz GH. Risk factors for the development of venous insufficiency of the lower limbs during pregnancy – Part 1 [article in Polish]. Ginekol Pol 2012; 83 (12) 939-942
• 84 Zhao MY, Zhao T, Meng QY, Zhao L, Li XC. Estrogen and estrogen receptor affects MMP2 and MMP9 expression through classical ER pathway and promotes migration of lower venous vascular smooth muscle cells. Eur Rev Med Pharmacol Sci 2020; 24 (03) 1460-1467
• 85 Ismail L, Normahani P, Standfield NJ, Jaffer U. A systematic review and meta-analysis of the risk for development of varicose veins in women with a history of pregnancy. J Vasc Surg Venous Lymphat Disord 2016; 4 (04) 518-524.e1
• 86 Raffetto JD. Inflammation in chronic venous ulcers. Phlebology 2013; 28 (Suppl. 01) 61-67
• 87 Mannello F, Ligi D, Canale M, Raffetto JD. Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease. Curr Vasc Pharmacol 2014; 12 (01) 173-185
• 88 Amato R, Dattilo V, Brescia C. et al. Th17-gene expression profile in patients with chronic venous disease and venous ulcers: genetic modulations and preliminary clinical evidence. Biomolecules 2022; 12 (07) 902
• 89 Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998; 15 (04) 342-349
• 90 Wrona M, Jöckel KH, Pannier F, Bock E, Hoffmann B, Rabe E. Association of venous disorders with leg symptoms: results from the Bonn Vein Study 1. Eur J Vasc Endovasc Surg 2015; 50 (03) 360-367
• 91 Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. UIP. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part I. Basic principles. Vasa 2007; 36 (01) 53-61
• 92 Hach W. Spezielle Diagnostik Der Primären Varikose: Untersuchungen Des Extrafaszialen Venensystems Unter Besonderer Berücksichtigung Der Aszendierenden Pressphlebographie. Demeter; 1981
• 93 Widmer L, Stähelin H, Nissen C, Da Silva A. Eds. Venen-, Arterien-Krankheiten, Koronare Herzkrankheit Bei Berufstätigen (Basler Studie I–III). Huber; 1981
• 94 Eklöf B, Rutherford RB, Bergan JJ. et al; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40 (06) 1248-1252
• 95 Lurie F, Passman M, Meisner M. et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020; 8 (03) 342-352
• 96 Porter JM, Moneta GL. International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg 1995; 21 (04) 635-645
• 97 McMullin GM, Coleridge Smith PD. An evaluation of Doppler ultrasound and photoplethysmography in the investigation of venous insufficiency. Aust N Z J Surg 1992; 62 (04) 270-275
• 98 Santler B, Goerge T. Chronic venous insufficiency - a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges 2017; 15 (05) 538-556
• 99 De Maeseneer MG, Kakkos SK, Aherne T. et al; ESVS Guidelines Committee. Editor's choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg 2022; 63 (02) 184-267
• 100 Mendoza E, Blättler W, Amsler F. Great saphenous vein diameter at the saphenofemoral junction and proximal thigh as parameters of venous disease class. Eur J Vasc Endovasc Surg 2013; 45 (01) 76-83
• 101 Menzinger G. Modern diagnostic methods of chronic venous insufficiency [article in German]. Wien Med Wochenschr 2016; 166 (9-10): 275-277
• 102 Molitor H, Kniajuk M. A new bloodless method for continuous recording of peripheral circulatory changes. J Pharmacol Exp Ther 1936; 57: 6-18
• 103 Nicolaides AN, Miles C. Photoplethysmography in the assessment of venous insufficiency. J Vasc Surg 1987; 5 (03) 405-412
• 104 Janssen MC, Claassen JA, van Asten WN, Wollersheim H, de Rooij MJ, Thien T. Validation of the supine venous pump function test: a new non-invasive tool in the assessment of deep venous insufficiency. Clin Sci (Lond) 1996; 91 (04) 483-488
• 105 van Bemmelen PS, van Ramshorst B, Eikelboom BC. Photoplethysmography reexamined: lack of correlation with duplex scanning. Surgery 1992; 112 (03) 544-548
• 106 Kerner J, Schultz-Ehrenburg U, Lechner W. Quantitative Photoplethysmographie bei gesunden Erwachsenen, Kindern und Schwangeren und bei Varizenpatienten. Phlebologie 1992; 21: 134-139
• 107 Nicolaides AN. Cardiovascular Disease Educational and Research Trust, European Society of Vascular Surgery, The International Angiology Scientific Activity Congress Organization, International Union of Angiology, Union Internationale de Phlebologie at the Abbaye des Vaux de Cernay. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation 2000; 102 (20) E126-E163
• 108 Abramowitz HB, Queral LA, Finn WR. et al. The use of photoplethysmography in the assessment of venous insufficiency: a comparison to venous pressure measurements. Surgery 1979; 86 (03) 434-441
• 109 Schultz-Ehrenburg U, Blazek V. Quantitative digital photoplethysmography (D-PPG): first results with on line registration and significance of V0 (venous pump power). In: Schultz-Ehrenburg U, Blazek V. eds. Advances in Computer Aided Noninvasive Vascular Diagnostics. VDI Verlag Düsseldorf; 1994
• 110 Blazek V, Schultz-Ehrenburg U, Fronek A. et al Quantitative Audio-Photoplethysmographie: Eine effective Screeningmesstechnik fur kontinuierliche, akustische Wiedergrabe peripherer Blutvolumenpulse. Phlebologie 1996; 25: 158-164
• 111 Ruehm SG, Wiesner W, Debatin JF. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience. Radiology 2000; 215 (02) 421-427
• 112 Chen CW, Tseng YH, Ngo YG, Yang TY, Huang YK. Vein of Giacomini detected through noncontrast magnetic resonance imaging plus QFlow for guided endovenous ablation. J Vasc Surg Venous Lymphat Disord 2022; 10 (06) 1376-1377
• 113 Wong MY, Chen CW, Tseng YH. et al. Noncontrast MRI in assessing venous reflux of legs using QFlow analysis and radial basis function neural network technique. Sci Rep 2023; 13 (01) 3263
• 114 Coelho A, O'Sullivan G. Usefulness of direct computed tomography venography in predicting inflow for venous reconstruction in chronic post-thrombotic syndrome. Cardiovasc Intervent Radiol 2019; 42 (05) 677-684
• 115 Gagne PJ, Tahara RW, Fastabend CP. et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord 2017; 5 (05) 678-687
• 116 Villalba L, Larkin TA. Transabdominal duplex ultrasound and intravascular ultrasound planimetry measures of common iliac vein stenosis are significantly correlated in a symptomatic population. J Vasc Surg Venous Lymphat Disord 2021; 9 (05) 1273-1281